Financing through the issuance of stock acquisition rights and shares
First written in FY2016. 23 of 25 entries say "Advanced", first in FY2017-Q1. Latest entry: FY2026.
115 other companies' latest entry also says "Advanced".
- FY2026AdvancedAnnual report
「1 April 2025–31 March 2026 9,303,200 82,680,236 363,091 2,214,855 363,091 3,621,167」
During the year, the exercise of stock acquisition rights increased the number of shares by 9,303,200 and increased capital stock and the capital reserve by ¥363.091 million each. - FY2026-H1AdvancedAnnual report
「During the interim consolidated accounting period, capital stock and capital surplus increased by ¥178.184 million each as a result of the exercise of stock acquisition rights.」
Share issuance through the exercise of stock acquisition rights continued, increasing the number of issued shares by 3,408,000 during the first half. An increase of 450,000 shares before the filing date was also reported. - FY2025-H1AdvancedAnnual report
「During the interim consolidated accounting period, capital stock and capital surplus increased by ¥121.780 million each as a result of the exercise of stock acquisition rights.」
The exercise of the 12th stock acquisition rights increased capital stock and capital surplus by ¥121.780 million each during the first half, and increased the total number of issued shares by 4,000,000. - FY2024AdvancedAnnual report
「During the fiscal year, 4,800,000 new shares were issued, raising ¥288 million.」
Share issuance and fundraising through the exercise of stock acquisition rights continued on a full-year basis, and ¥287.690 million in proceeds from the issuance of shares through the exercise of stock acquisition rights was recorded in the consolidated cash flows. - FY2024-Q3AdvancedAnnual report
「During the cumulative third quarter, capital stock and capital surplus increased by ¥94.379 million each as a result of the exercise of stock acquisition rights.」
Fundraising through the exercise of the 12th stock acquisition rights progressed during the cumulative third quarter, increasing capital stock and capital surplus by ¥94.379 million each. - FY2024-Q2AdvancedAnnual report
「During the cumulative second quarter, capital stock and capital surplus increased by ¥63.934 million each as a result of the exercise of stock acquisition rights.」
The exercise of the 12th stock acquisition rights increased capital stock and capital surplus by ¥63.934 million each during the cumulative second quarter, and cash flow from financing activities resulted in an inflow of ¥125.810 million. - FY2024-Q1AdvancedAnnual report
「1 April 2023–30 June 2023 500,000 52,009,516 15,222 1,003,693 15,222 2,305,200 (Note) The increase resulted from the exercise of the 12th stock acquisition rights.」
In the first quarter, the exercise of the 12th stock acquisition rights increased the number of shares by 500,000 and increased capital stock and the capital reserve by ¥15.222 million each. - FY2023AdvancedAnnual report
「The exercise of the 11th stock acquisition rights issued 206,800 new shares and raised ¥15.021 million in May 2021. In addition, the third-party allotment conducted in April 2022 and the exercise of the 12th stock acquisition rights resulted in the issuance of 12,663,300 new shares and raised ¥763.651 million during the fiscal year.」
The exercise of the 11th and 12th stock acquisition rights and the third-party allotment advanced share issuance and fundraising during the year. - FY2023-Q3AdvancedAnnual report
「During the cumulative third quarter, capital stock and capital surplus increased by ¥364.980 million each as a result of the third-party allotment and the exercise of stock acquisition rights.」
The third-party allotment and exercise of the 12th stock acquisition rights increased capital stock and capital surplus by ¥364.980 million each, bringing the total number of issued shares to 49,014,600. - FY2023-Q2AdvancedAnnual report
「During the cumulative second quarter, capital stock and capital surplus increased by ¥316.268 million each as a result of the third-party allotment and the exercise of stock acquisition rights.」
The third-party allotment and exercise of stock acquisition rights increased capital stock and capital surplus by ¥316.268 million each. The number of issued shares at the end of the second quarter was 47,414,600. - FY2023-Q1AdvancedAnnual report
「Payment in full for the total amount of the new shares and the total amount of the stock acquisition rights has been completed.」
On 25 April 2022, payment for 8,333,300 new shares issued through a third-party allotment was completed, and 166,666 of the 12th stock acquisition rights were issued. The 12th stock acquisition rights represent 16,666,600 potential shares and may be exercised from 26 April 2022 to 25 April 2025. - FY2022-Q3AdvancedAnnual report
「During the cumulative third quarter, capital stock and capital surplus increased by ¥266.740 million each as a result of the exercise of stock acquisition rights. At the end of the third quarter, capital stock was ¥599.133 million and capital surplus was ¥1,458.643 million.」
The exercise of the 11th stock acquisition rights and other rights increased capital stock and capital surplus by ¥266.740 million each during the cumulative third quarter. Fundraising through stock acquisition rights has continued. - FY2022-Q2AdvancedAnnual report
「During the cumulative second quarter, capital stock and capital surplus increased by ¥214.944 million each as a result of the exercise of stock acquisition rights.」
The exercise of the 11th stock acquisition rights and other rights increased capital stock and capital surplus by ¥214.944 million each. Fundraising through the exercise of stock acquisition rights is making concrete progress. - FY2022-Q1AdvancedAnnual report
「During the cumulative first quarter, capital stock and capital surplus increased by ¥179.835 million each as a result of the exercise of stock acquisition rights.」
In the first quarter, 3,348,400 shares were issued through the exercise of the 10th and 11th stock acquisition rights, increasing capital stock and the capital reserve by ¥179.835 million each. A total of 20,918 of the 11th stock acquisition rights were exercised, raising ¥186.537 million. - FY2021AdvancedAnnual report
「(4) Number of potential shares issued through the issuance 14,000,000 shares」
While partially exercising the 10th Series of Stock Acquisition Rights and acquiring and cancelling the remaining rights, the Company issued 140,000 units of the 11th Series of Stock Acquisition Rights, representing 14,000,000 potential shares, and announced a financing plan of up to ¥1,729.081 million. The planned uses of funds include working capital, new product development and advertising, and investment in business expansion. - FY2021-Q3AdvancedAnnual report
「Between 1 January 2021 and 31 January 2021, the exercise of stock acquisition rights increased the total number of issued shares by 320,000 and increased share capital and capital reserves by ¥22.044 million each.」
Regarding the 10th Series of Stock Acquisition Rights, 320,000 rights were exercised in January 2021 before the filing date, increasing share capital and capital reserves by ¥22.044 million each. Financing through the third-party allotment progressed further. - FY2021-Q2AdvancedAnnual report
「As a result, ¥150.001 million was transferred to each of share capital and capital reserves, bringing share capital to ¥250.001 million and capital reserves to ¥1,454.897 million.」
The Company issued 2,189,800 common shares and 50,806 units of the 10th Series of Stock Acquisition Rights through a third-party allotment. It planned to raise ¥300,002,600 from the new shares and ¥700,005,068 through the stock acquisition rights, and specified the use and timing of expenditures for the funds raised. - FY2019RestatedAnnual report
「The Company raises funds for investments through equity financing, including stock acquisition rights.」
Although there was no exercise of stock acquisition rights or issuance of shares during the fiscal year, the policy of raising investment funds through equity financing continues. - FY2018AdvancedAnnual report
「The increase of 9,401,800 issued shares resulted from the exercise of stock acquisition rights.」
During the consolidated fiscal year, the exercise of stock acquisition rights increased the number of shares by 9,401,800, resulting in ¥1,258.775 million in proceeds from the issuance of shares and increases of ¥633.916 million each in share capital and capital reserves. - FY2018-Q3AdvancedAnnual report
「During the nine months ended the third quarter, the Company received payments of ¥150.013 million on 21 April 2017, ¥30.002 million on 23 June 2017 and ¥40.200 million on 25 October 2017 upon the exercise of the 9th Series of Stock Acquisition Rights of Oak Capital Co., Ltd.」
The Company received total payments of ¥220.215 million during the nine months ended the third quarter through the exercise of the 9th Series of Stock Acquisition Rights, increasing share capital and capital reserves by ¥110.806 million each. - FY2018-Q2AdvancedAnnual report
「During the six months ended the second quarter, the Company received payments of ¥150.013 million on 21 April 2017 and ¥30.002 million on 23 June 2017 upon the exercise of the 9th Series of Stock Acquisition Rights of Oak Capital Co., Ltd.」
The Company received total payments of ¥180.015 million during the six months ended the second quarter through the exercise of the 9th Series of Stock Acquisition Rights, increasing share capital and capital reserves by ¥90.578 million each. In addition, on 25 October 2017, a further 300,000 shares were issued and share capital and capital reserves each increased by ¥20.227 million. - FY2018-Q1AdvancedAnnual report
「1 April 2017 to 30 June 2017: Change in total number of issued shares: 1,343,400 shares」
The exercise of stock acquisition rights increased the number of shares by 1,343,400 during the quarter, and increased share capital and capital reserves by ¥90.578 million each. - FY2017-Q2AdvancedAnnual report
「1 July 2016 to 30 September 2016: Change in total number of issued shares: 522,400 shares」
The exercise of stock acquisition rights increased the number of shares by 522,400 during the second quarter alone. Proceeds from the issuance of shares for the six months ended the second quarter were ¥208.954 million. - FY2017-Q1AdvancedAnnual report
「During the six months ended the first quarter, the Company received payments of ¥40.012 million on 27 April 2016 and ¥100.004 million on 31 May 2016 upon the exercise of the 9th Series of Stock Acquisition Rights of Oak Capital Co., Ltd.」
The Company received total payments of ¥140.016 million during the quarter through the exercise of the 9th Series of Stock Acquisition Rights, increasing share capital and capital reserves by ¥70.452 million each. - FY2016First statedAnnual report
「Net cash provided by financing activities was ¥1,251.362 million. This was mainly due to ¥1,237.760 million in proceeds from the issuance of shares and ¥18.640 million in proceeds from the issuance of stock acquisition rights.」
The Company raised funds during the fiscal year through the issuance of shares and stock acquisition rights, resulting in net assets of ¥1,468.651 million.